| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
| 07/03/2003 | US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 07/03/2003 | US20030125356 Reacting a methylketophenolic compound with a benzaldehyde compound to produce an intermediate, cyclizing the intermediate in presence of a base; anticarcinogenic agent, and treats diseases induced by cell proliferation |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125344 Rho-kinase inhibitors |
| 07/03/2003 | US20030125343 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/03/2003 | US20030125339 Substituted alkylamine derivatives and methods of use |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease |
| 07/03/2003 | US20030125330 Anxiolytics and antidepressants |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | US20030125316 Cardiovascular disorders including atherosclerosis and other coronary artery disease; anticholesterol agents; antilipemia agents; nontoxic; prophylactic; e.g., 2,3,4,5-tetrahydro-1-benzothiepine 1,1-dioxide and nicotinic acid or nigeritrol |
| 07/03/2003 | US20030125299 Method for treating or preventing inflammatory diseases |
| 07/03/2003 | US20030125294 Selective toxin expression in angiogenic endothelial cells |
| 07/03/2003 | US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125257 A olilgopeptide or polypeptide containing Leustatin, Chastatin or Tyrstatin |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 07/03/2003 | US20030124636 Monitoring metabolic phenotypes of bradycardial agents; immunoassays |
| 07/03/2003 | US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 07/03/2003 | US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 07/03/2003 | US20030124557 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function |
| 07/03/2003 | US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 07/03/2003 | US20030124150 Kit for reducing aching |
| 07/03/2003 | US20030124129 Angiopoietin-2 specific binding agents |
| 07/03/2003 | US20030124116 Antibodies binding to polypeptides encoded by the genes |
| 07/03/2003 | US20030124100 Includes an endothelial specific enhancer element; especially modifications of the PPE promoter, which enhance its expression in response to hypoxia and angiogenesis. |
| 07/03/2003 | US20030124056 Carrier molecules |
| 07/03/2003 | CA2849201A1 Adipose-derived cell processing unit |
| 07/03/2003 | CA2473862A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | CA2471263A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/03/2003 | CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 07/03/2003 | CA2471096A1 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 07/03/2003 | CA2471089A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | CA2471087A1 Pyrazolyl-substituted triazoloquinoxalines |
| 07/03/2003 | CA2471085A1 Aroyl pyridinones |
| 07/03/2003 | CA2471057A1 Benzothia(dia)zine derivatives and their use as ampa modulators |
| 07/03/2003 | CA2470931A1 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 07/03/2003 | CA2470603A1 Methods for the treatment of peripheral neural and vascular ailments |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2470591A1 Therapeutic compounds for treating dyslipidemic conditions |
| 07/03/2003 | CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | CA2470148A1 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration |
| 07/03/2003 | CA2469884A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 07/03/2003 | CA2469372A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production |
| 07/03/2003 | CA2469370A1 Adipose-derived cell processing unit |
| 07/03/2003 | CA2469042A1 Triazoles as oxytocin antagonists |
| 07/03/2003 | CA2468083A1 Use of heterocyclic carboxamides to treat anemia |
| 07/03/2003 | CA2466928A1 Treatment of neurodegenerative and cardiovascular disorders |
| 07/03/2003 | CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323736A1 Chimeric human-type vascular endothelial cell growth factor |
| 07/02/2003 | EP1323719A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
| 07/02/2003 | EP1323713A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 07/02/2003 | EP1323712A1 Process for producing multiform crystal of donepezil hydrochloride |
| 07/02/2003 | EP1323711A1 Novel phenylalanine derivatives |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322759A2 Potassium channel interactors and uses therefor |
| 07/02/2003 | EP1322755A1 Human and mouse targeting peptides identified by phage display |
| 07/02/2003 | EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 07/02/2003 | EP1322673A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 07/02/2003 | EP1322647A1 Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt and process for their preparation |
| 07/02/2003 | EP1322643A1 Piperazin-2-one amides as inhibitors of factor xa |
| 07/02/2003 | EP1322642A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 07/02/2003 | EP1322641A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 07/02/2003 | EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 07/02/2003 | EP1322632A1 N-disubstituted carbamoyloxy flavones |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322630A2 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
| 07/02/2003 | EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists |
| 07/02/2003 | EP1322624A1 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 07/02/2003 | EP1322623A2 Hydroxy acid integrin antagonists |
| 07/02/2003 | EP1322619A1 Isoquinolinone potassium channel inhibitors |
| 07/02/2003 | EP1322618A1 Amino heterocyclic compounds (factor x a? inhibitors 14) |
| 07/02/2003 | EP1322617A1 Compounds and methods for modulation of estrogen receptors |
| 07/02/2003 | EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 07/02/2003 | EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1322602A1 Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and to a medicament containing these compounds |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 07/02/2003 | EP1322336A1 Method of increasing testosterone and related steroid concentrations in women |
| 07/02/2003 | EP1322322A2 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 07/02/2003 | EP1322310A1 Alpha v integrin receptor antagonists |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP1322300A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 07/02/2003 | EP1322297A2 Chrono delivery formulations and method of use thereof |
| 07/02/2003 | EP1322220A2 Methods for analyzing and using data from hypertensive patients |
| 07/02/2003 | EP1322176A1 Use of carnitine for enhancing training-induced bradycardia |
| 07/02/2003 | EP1240177B1 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use |
| 07/02/2003 | EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/02/2003 | EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 07/02/2003 | EP1140861B1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 07/02/2003 | EP0991627B1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 07/02/2003 | EP0954292B1 Pharmaceutical formulations with delayed drug release |
| 07/02/2003 | EP0944582B1 Ketobenzamides as calpain inhibitors |